Hikal Ltd (BOM:524735)
₹ 359.55 -6.4 (-1.75%) Market Cap: 44.33 Bil Enterprise Value: 51.67 Bil PE Ratio: 63.36 PB Ratio: 3.86 GF Score: 78/100
Back to the Transcripts List

Q2 2025 Hikal Ltd Earnings Call Transcript

Nov 12, 2024 / 11:00 AM GMT
Release Date Price: ₹384.75 (+2.31%)

Key Points

Positve
  • Hikal Ltd (BOM:524735) reported a significant revenue growth of 29% year-on-year for Q2 FY25, with EBITDA increasing by 30%.
  • The company has successfully validated six products in its pharmaceutical division, with plans to validate more in the coming months.
  • Hikal Ltd has improved its working capital and cash flow, reducing working capital by 50 crores.
  • The pharmaceutical business showed strong performance with a 9% year-on-year revenue increase, driven by successful customer acquisition and increased demand.
  • The company is well-positioned to capitalize on the China plus one strategy, particularly in the CDMO sector, with a healthy pipeline and technological advancements.
Negative
  • The crop protection business experienced a 4% decline in value despite a 22% increase in volume, indicating pricing pressures.
  • Finance costs and depreciation from recent asset additions impacted profit before and after tax.
  • The crop protection sector is still facing challenges with excess inventory and is expected to take a few more quarters to stabilize.
  • The company faces competition from China in the crop protection business, particularly in older generic molecules.
  • Hikal Ltd's debt remains a concern, with a repayment of 130 crores expected next year, and ongoing investments in assets.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HIKA.NS - Hikal Ltd
Q2 2025 Hikal Ltd Earnings Call
Nov 12, 2024 / 11:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to Haer Limited Q2 F 525 earnings conference call as a reminder, all participant line will be in listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need any assistance during the conference call? Please signal an operator by pressing star then zero on your touchtone phone. Please note that this conference is being recorded.

I now hand the conference over to Mr Samir Hirama, Managing Director of Haer Limited. Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.